Option Care Health (NYSE: OPCH), the home-based and alternate site infusion services provider, had one heck of a 2023. But, about six months removed from its failed attempt to acquire Amedisys Inc. (Nasdaq: AMED), it still remains a home-based care provider worth paying attention to. On Tuesday at the J.P. Morgan Healthcare Conference, the company’s leaders laid out their strategy moving forward. They also didn’t take future home health M&A off the table, but did offer a few key caveats.
Read the full article: Option Care Health Leaders: ‘We Learned a Lot’ from Failed Amedisys Acquisition //
Source: https://homehealthcarenews.com/2024/01/option-care-health-leaders-we-learned-a-lot-from-failed-amedisys-acquisition